Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
10.13
+0.32 (3.26%)
May 13, 2026, 9:35 AM EDT - Market open
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $86.23 million as of May 13, 2026. Its market cap has increased by 101.00% in one year.
Market Cap
86.23M
Enterprise Value
84.22M
1-Year Change
101.00%
Ranking
Category
Stock Price
$10.13
Market Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $86.23M, a decrease of -59.95%. That is a compound annual growth rate of -7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 71.80M | -44.94% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
| Oct 16, 2014 | 215.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 87.40M |
| Champions Oncology | 87.07M |
| PolyPid | 85.97M |
| OKYO Pharma | 85.02M |
| eXoZymes | 83.77M |
| Adicet Bio | 83.48M |
| Acrivon Therapeutics | 80.89M |
| Gossamer Bio | 79.94M |